GNI Group Ltd (2160) Stock Price & News

Why is 2160 down 3.35%?

Dive Deeper

2160:TYO

GNI Group Ltd

¥2,392.00

-3.35%

(-83.00) 1D

Nov 4, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 2160...

Open

¥2,375

High

¥2,404

Low

¥2,222

Mkt. cap

157.52B

Avg. vol.

2.34M

Volume

3.83M

52-wk high

¥3,740

52-wk low

¥2,112

EPS

-¥95

Shares outstanding

13.51M

No. of employees

990

Open

¥2,375

High

¥2,404

Low

¥2,222

Mkt. cap

157.52B

Avg. vol.

2.34M

Volume

3.83M

52-wk high

¥3,740

52-wk low

¥2,112

EPS

-¥95

Shares outstanding

13.51M

No. of employees

990

Related stocks

4588

Oncolys Biopharma Inc

CanBas Co Ltd (Parent)

¥708.00

-2.75%

News stories

From web sources and news partners

MarketWatch

49 minutes ago

Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress

FinancialContent

21 minutes ago

Corpay’s (NYSE:CPAY) Q3 2026 sales beat estimates

shattered.io

16 minutes ago

S&P Earnings Jump 30.2% as Big Tech Cash Flow Sinks [2026]

WHDH

9 minutes ago

Stocks surge, and the Dow soars 1,500 points as oil prices tumble following the US midterm elections

About GNI Group Ltd

CEO-

Employees990

FoundedNov 20, 2001

Headquarters-

SectorBiotechnology

Industry-

Websitegnipharma.com

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	7.10B	7.48B	5.53B	6.41B
Cost of goods sold	1.56B	1.86B	1.50B	1.81B
Cost of revenue	1.56B	1.86B	1.50B	1.81B
Research and development expenses	849.47M	852.00M	1.05B	1.07B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.95B	7.04B	5.46B	5.96B
Operating expense	4.86B	7.62B	6.77B	1.32B
Total operating expenses	6.42B	9.49B	8.27B	3.13B
Operating income	683.54M	-2.01B	-2.75B	3.28B
Other non operating income	-2.00M	203.00M	-	-1.00M
EBT including unusual items	349.95M	-3.55B	-3.19B	3.10B
EBT excluding unusual items	349.95M	-2.38B	-3.19B	3.10B
Income tax expense	82.20M	1.52B	189.00M	311.00M
Effective tax rate	23.49%	-42.96%	-5.93%	10.04%
Other operating expenses	54.93M	-267.00M	262.00M	-5.71B
Net income	420.38M	-3.75B	-2.13B	139.00M
Net profit margin	5.92%	-50.10%	-38.49%	2.17%
Earnings per share	-	-	-	-
Interest and investment income	73.70M	-	-	252.00M
Interest expense	-403.17M	-584.00M	-588.00M	-276.00M
Net interest expenses	-329.47M	-584.00M	-588.00M	-24.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	971.65M	-1.70B	-2.44B	3.60B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything